Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells. Swerts, K., Moerloose, B. D., Dhooge, C. R, Vandesompele, J., Hoyoux, C., Beiske, K., Benoit, Y., Laureys, G., & Philippé, J. Clinical chemistry, 52(3):438--45, March, 2006.
Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells. [link]Paper  abstract   bibtex   
Reliable detection of neuroblastoma cells in bone marrow (BM) is critical because BM involvement influences staging, risk assessment, and evaluation of therapeutic response in neuroblastoma patients. Standard cytomorphologic examination of BM aspirates is sensitive enough to detect single tumor cells. Consequently, more sensitive and specific detection methods are indispensable.
@article{ Swerts2006,
  author    = {Katrien Swerts and Barbara De Moerloose and Catharina R Dhooge and Jo Vandesompele and Claire Hoyoux and Klaus Beiske and Yves Benoit and Geneviève Laureys and Jan Philippé},
  title     = {Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.},
  journal   = {Clinical chemistry}, 
  abstract   = {Reliable detection of neuroblastoma cells in bone marrow (BM) is critical because BM involvement influences staging, risk assessment, and evaluation of therapeutic response in neuroblastoma patients. Standard cytomorphologic examination of BM aspirates is sensitive enough to detect single tumor cells. Consequently, more sensitive and specific detection methods are indispensable.},
  issn   = {0009-9147},
  month   = {March},
  pages   = {438--45},
  volume   = {52},
  number   = {3},
  url   = {http://www.ncbi.nlm.nih.gov/pubmed/16384890} ,
  year   = {2006}
}

Downloads: 0